We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Bcl-10 (N-Terminus) antibody
B-cell lymphoma/leukemia 10
B-cell CLL/lymphoma 10, Bcl-10
CARD-containing molecule enhancing NF-kappa-B
CARD-like apoptotic protein, hCLAP
CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER
Cellular homolog of vCARMEN, cCARMEN
Cellular-E10, c-E10
Mammalian CARD-containing adapter molecule E10, mE10
Gene name: BCL10, CARMEN, CIPER, CLAP, IMD37
B-cell CLL/lymphoma 10, Bcl-10
CARD-containing molecule enhancing NF-kappa-B
CARD-like apoptotic protein, hCLAP
CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER
Cellular homolog of vCARMEN, cCARMEN
Cellular-E10, c-E10
Mammalian CARD-containing adapter molecule E10, mE10
Gene name: BCL10, CARMEN, CIPER, CLAP, IMD37
As low as
€671.00
In stock
Ref
00097749
Overexpression of Bcl10 induces JNK, p38, and NF- B activation. Bcl10 interacts with caspase- 9, enhances pro-caspase-9 processing, and induces apoptosis through caspase-9 activation. Bcl10 exhibits a variety of mutations in MALT lymphoma and in B and T cell lymphomas indicating that it may be commonly involved in the pathogenesis of human tumors. Bcl10 is expressed in many human and murine tissues and cell lines.
ID Covalab | pab60043 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | Synthetic peptide corresponding to aa 5-19 (N-terminus ) of human Bcl-10 |
Activity cross reaction | Reacts with human Bcl-10. |
Species | Hu |
Labelling | None |
Form | Purified |
Preservative | NaN3 0.02% |
Storage instructions | Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles. |
Target | Bcl-10 |
Uniprot ID | O95999 |
Gene ID | 8915 |
Applications | ICC, IF, IHC - P, WB |
Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only: IHC-P (10 µg/ml) WB (1 µg/ml) ICC (1 µg/ml) |
Write Your Own Review